{"id":8606,"date":"2022-02-08T13:35:21","date_gmt":"2022-02-08T18:35:21","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/when-is-a-drug-considered-defective\/"},"modified":"2022-02-08T13:35:21","modified_gmt":"2022-02-08T18:35:21","slug":"ne-zaman-bir-ilac-kusurlu-oldugu-kabul-edilir","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/ne-zaman-bir-ilac-kusurlu-oldugu-kabul-edilir\/","title":{"rendered":"Bir \u0130la\u00e7 Ne Zaman Ar\u0131zal\u0131 Kabul Edilir?"},"content":{"rendered":"<p>Baz\u0131 insanlar, FDA&#039;n\u0131n (G\u0131da ve \u0130la\u00e7 \u0130daresi) hat\u0131rlamas\u0131 durumunda bir ilac\u0131n kusurlu oldu\u011funa inan\u0131r. 2017 ve 2019 y\u0131llar\u0131 aras\u0131nda FDA, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7395820\/\" target=\"_blank\" rel=\"noopener\">y\u0131lda yetmi\u015f uyu\u015fturucu<\/a>.<\/p>\n<p>Bununla birlikte, \u00e7o\u011funlukla a\u015fa\u011f\u0131da belirtilen nedenlerden dolay\u0131, FDA ila\u00e7lar\u0131 yaln\u0131zca a\u015f\u0131r\u0131 durumlarda geri \u00e7a\u011f\u0131r\u0131r.<\/p>\n<p>Ayr\u0131ca, i\u015fler o noktaya geldi\u011finde, bir\u00e7ok insan zaten ciddi \u015fekilde yaralanm\u0131\u015ft\u0131r. Ek olarak, bildirilen yaralanma istatistikleri genellikle buzda\u011f\u0131n\u0131n sadece g\u00f6r\u00fcnen k\u0131sm\u0131d\u0131r.<\/p>\n<p>Kusurlu ila\u00e7 tan\u0131m\u0131 hukuk mahkemesinde \u00e7ok daha geni\u015ftir. Bu forumda kusurlu bir ila\u00e7, temelde ciddi bir yaralanmaya neden olabilecek herhangi bir ila\u00e7t\u0131r. Bu standart, ne yedikleri hakk\u0131nda hi\u00e7bir fikri olmayan insanlar\u0131 korumak i\u00e7in gereklidir.<\/p>\n<p>Ancak bu standart, FDA eylemini tetiklemek i\u00e7in yeterli de\u011fildir.<\/p>\n<p>A <a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/\">New York ki\u015fisel yaralanma avukat\u0131<\/a> yaralanma iddialar\u0131n\u0131 takip ederek insanlar\u0131 g\u00fcvende tutun. Bu durumlarda ortaya \u00e7\u0131kan zararlar, \u00f6zellikle de cezai zararlar, ila\u00e7 \u015firketlerini i\u015f yapma bi\u00e7imlerini de\u011fi\u015ftirmeye ve insanlar\u0131 k\u00e2rdan \u00f6nde tutmaya te\u015fvik ediyor.<\/p>\n<h2>FDA Onay S\u00fcreci<\/h2>\n<p>Milletvekilleri, 1900&#039;lerin ba\u015f\u0131nda G\u0131da ve \u0130la\u00e7 \u0130daresini kurdu. O zamandan \u00f6nce, herhangi bir nedenle herhangi birine bir \u015fey satmak yasald\u0131. 1890&#039;lar\u0131n sonlar\u0131nda Bayer, hem aspirin hem de eroin satmaya ba\u015flad\u0131. Ba\u015flang\u0131\u00e7ta, \u015firket eroini bir a\u011fr\u0131 kesici olarak pazarlad\u0131. Daha sonra piyasaya <a href=\"https:\/\/www.businessinsider.com\/yes-bayer-promoted-heroin-for-children-here-are-the-ads-that-prove-it-2011-11\" target=\"_blank\" rel=\"noopener\">\u00c7ocuklarda \u00f6ks\u00fcr\u00fck kesici olarak eroin<\/a>.<\/p>\n<p>Uzun y\u0131llar boyunca FDA, insanlar\u0131 g\u00fcvende tutmak i\u00e7in m\u00fccadele eden etkili bir t\u00fcketici izleme kurumuydu.<\/p>\n<p>Bug\u00fcn, kullan\u0131c\u0131 \u00fccretleri <a href=\"https:\/\/www.fda.gov\/about-fda\/fda-basics\/fact-sheet-fda-glance\" target=\"_blank\" rel=\"noopener\">y\u00fczde 65<\/a> insan ila\u00e7 d\u00fczenlemesi a\u00e7\u0131s\u0131ndan FDA&#039;n\u0131n gelirinin. Ba\u015fka bir deyi\u015fle, FDA, ila\u00e7 \u015firketlerini d\u00fczenlemek i\u00e7in neredeyse tamamen ila\u00e7 \u015firketlerinden gelen paraya ba\u011f\u0131ml\u0131d\u0131r.<\/p>\n<p>Sat\u0131\u015fa sunulan ila\u00e7 say\u0131s\u0131 ne kadar azsa, gelir o kadar d\u00fc\u015f\u00fck olur.<\/p>\n<p>FDA&#039;n\u0131n yap\u0131s\u0131 sorunlu olarak g\u00f6r\u00fclebilir, \u00e7\u00fcnk\u00fc ayn\u0131 b\u00fcrokratlar genellikle ila\u00e7lar\u0131 onaylar ve geri \u00e7a\u011f\u0131rmalar yapar. FDA bir geri \u00e7a\u011f\u0131rma yay\u0131nlarsa, esasen bir hata yapt\u0131\u011f\u0131n\u0131 ve ilac\u0131 onaylamamas\u0131 gerekti\u011fini kabul ediyor. Kimse b\u00f6yle itiraflarda bulunmaktan ho\u015flanmaz.<\/p>\n<p>2010&#039;lar\u0131n ba\u015f\u0131nda, FDA b\u00fcrokratlar\u0131 510(k) h\u0131zland\u0131r\u0131lm\u0131\u015f onay s\u00fcrecini ba\u015flatt\u0131. Bir ila\u00e7 &quot;\u00e7\u0131\u011f\u0131r a\u00e7an&quot; bir \u00fcr\u00fcnse ve B kelimesi \u00e7ok iyi tan\u0131mlanmam\u0131\u015fsa, ajans bunu bir y\u0131ldan k\u0131sa bir s\u00fcre i\u00e7inde onaylayabilir.<\/p>\n<h2>Tazminat Talebiniz<\/h2>\n<p>G\u00fcn\u00fcm\u00fcz ila\u00e7lar\u0131 \u00e7ok g\u00fc\u00e7l\u00fc oldu\u011fu i\u00e7in hepsinin riskleri ve yan etkileri var.<\/p>\n<p>Ancak ila\u00e7 \u015firketlerinin bir <a href=\"https:\/\/www.nacds.org\/pdfs\/membership\/duty_to_warn.pdf\" target=\"_blank\" rel=\"noopener\">uyarma g\u00f6revi<\/a> T\u00fcketiciler bu riskler hakk\u0131nda Bu uyar\u0131 spesifik, makul bir \u015fekilde riske g\u00f6re uyarlanm\u0131\u015f ve olduk\u00e7a g\u00f6r\u00fcn\u00fcr olmal\u0131d\u0131r.<\/p>\n<p>\u201cBu ila\u00e7 a\u015fa\u011f\u0131daki ciddi yan etkilere neden olabilir\u201d gibi jenerik bir ifadenin kullan\u0131m talimat\u0131n\u0131n bir yerine g\u00f6m\u00fclmesi normalde yeterli de\u011fildir.<\/p>\n<p>Genellikle ila\u00e7 \u00fcreticileri bu t\u00fcr ciddi yan etkilerin tamamen fark\u0131ndad\u0131r.<\/p>\n<p>\u015eirketler genellikle bir ilac\u0131n g\u00fcvenli\u011fini ve etkilili\u011fini \u00f6ne \u00e7\u0131karaca\u011f\u0131n\u0131 umduklar\u0131 devam eden ara\u015ft\u0131rmalar y\u00fcr\u00fct\u00fcrler.<\/p>\n<p>Bu \u00e7al\u0131\u015fmalar olumsuz sonu\u00e7 verirse, \u015firket genellikle bu t\u00fcr sonu\u00e7lar\u0131 g\u00f6mer, b\u00f6ylece ila\u00e7 sat\u0131\u015flar\u0131 olumsuz etkilenmez.<\/p>\n<p>Mahkemede zarar\u0131 kan\u0131tlamak i\u00e7in, New York ki\u015fisel yaralanma avukatlar\u0131 genellikle hastal\u0131k art\u0131\u015flar\u0131n\u0131 ararlar. Belirli say\u0131da insan belirli bir ilac\u0131 ald\u0131ysa ve hepsinde ayn\u0131 ciddi hastal\u0131k geli\u015ftiyse, hastal\u0131\u011fa ilac\u0131n neden olmama olas\u0131l\u0131\u011f\u0131 daha y\u00fcksektir.<\/p>\n<p>Avukatlar da bilirki\u015filere g\u00fcvenirler. Bu birinci s\u0131n\u0131f doktorlar, \u00fcr\u00fcn g\u00fcvenli\u011fi hakk\u0131nda bilin\u00e7li bir karar verebilmeleri i\u00e7in \u00e7al\u0131\u015fmalar\u0131n sonu\u00e7lar\u0131n\u0131 ve di\u011fer kan\u0131tlar\u0131 j\u00fcri \u00fcyelerine a\u00e7\u0131klar.<\/p>\n<p>Kusurlu ila\u00e7 iddialar\u0131ndaki yayg\u0131n ila\u00e7 \u015firketi savunmalar\u0131, nedensellik eksikli\u011fini ve zaman a\u015f\u0131m\u0131n\u0131 i\u00e7erir.<\/p>\n<p>Nedenselli\u011fe gelince, ila\u00e7 \u015firketlerinin genellikle kendi &quot;uzmanlar\u0131&quot; ilac\u0131n g\u00fcvenli oldu\u011funa tan\u0131kl\u0131k eder. Bu testler olduk\u00e7a \u00f6znel oldu\u011fu i\u00e7in, bu arg\u00fcman genellikle j\u00fcri \u00fcyeleri aras\u0131nda ilgi g\u00f6r\u00fcyor.<\/p>\n<p>Zamana\u015f\u0131m\u0131 s\u00fcresine gelince, yasaya g\u00f6re, ma\u011fdurlar\u0131n ihmal iddias\u0131nda bulunmak i\u00e7in yaralanma tarihinden itibaren yaln\u0131zca iki y\u0131l\u0131 vard\u0131r. Kanser gibi tehlikeli bir ilac\u0131n etkileri genellikle y\u0131llarca ortaya \u00e7\u0131kmaz.<\/p>\n<p>Belirsiz bir yasal doktrin, gecikmeli ke\u015fif kural\u0131, genellikle bu durumlarda kurbanlar\u0131 korur.<\/p>\n<p>Ar\u0131zal\u0131 ila\u00e7lar genellikle ciddi yaralanmalara neden olur. ile \u00fccretsiz dan\u0131\u015fma i\u00e7in <a href=\"\/tr\/bize-ulasin\/\">New York&#039;ta deneyimli ki\u015fisel yaralanma avukat\u0131<\/a>, contact Napoli Shkolnik . We do not charge upfront legal fees and only recover a fee when we win your case.<\/p>","protected":false},"excerpt":{"rendered":"<p>Baz\u0131 insanlar, FDA&#039;n\u0131n (G\u0131da ve \u0130la\u00e7 \u0130daresi) hat\u0131rlamas\u0131 durumunda bir ilac\u0131n kusurlu oldu\u011funa inan\u0131r. 2017 ile 2019 aras\u0131nda FDA y\u0131lda yakla\u015f\u0131k yetmi\u015f ilac\u0131 geri \u00e7a\u011f\u0131rd\u0131. Yine de,\u2026<\/p>","protected":false},"author":3,"featured_media":8607,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[816,820,875,881,1065],"class_list":["post-8606","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-defective-products","tag-product-liability","tag-bad-drugs","tag-doctor-mistakes","tag-misdiagnosis"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=8606"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8606\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/8607"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=8606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=8606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=8606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}